Tacrolimus inhibits discordant islet xenograft rejection: a study in the pig‐to‐rat model

Abstract: The aim of the present study was to evaluate the immunosuppressive effect of tacrolimus (TAC) in discordant islet xenotransplantation. Fetal porcine islet‐like cell clusters (ICCs) were transplanted under the kidney capsule in normoglycemic rats treated with TAC monotherapy, TAC plus other immunosuppressive drugs or cyclosporin A (CsA) monotherapy. Twelve or 24 days after transplantation, the extent of a cellular infiltration in the xenografts was evaluated using immunohistochemistry. In some animals, the grafts were examined for antibody and complement deposition and the levels of xenoreactive antibodies in serum were determined. In untreated rats, the xenografts were completely rejected after 12 days and no intact ICCs remained. TAC monotherapy (at 0.5 and 1.0 mg/kg b.w.) almost completely inhibited rejection for up to 12 days. In animals treated with TAC monotherapy (at 0.5 mg/kg b.w.), rejection was markedly inhibited for up to 24 days. However, the effect after 24 days was not consistent and in some grafts there were signs of rejection. The protective effect of TAC observed in this study is in contrast to the findings in rats given CsA monotherapy in which no or only a marginal effect on islet xenograft rejection was observed. Only when CsA was given at 20 mg/kg b.w., an inhibitory effect could be observed. Immunosuppression with TAC at a suboptimal dose (0.3 mg/kg b.w.) plus 15‐deoxyspergualin or brequinar also had an inhibitory effect on the rejection. In animals given TAC plus mycophenolate mofetil, a protective effect was observed as well; however, this effect was not consistent.

[1]  O. Korsgren,et al.  Xenotransplanting Pancreatic Islets , 2001 .

[2]  O. Korsgren,et al.  Allogeneic and xenogeneic islets are rejected by different and specific mechanisms: A study in rodents using a mixed allogeneic‐xenogeneic islet transplantation model , 1997 .

[3]  O. Korsgren,et al.  Efficacy of immunosuppressive drugs in islet xenotransplantation: leflunomide in combination with cyclosporine and mycophenolate mofetil prevents islet xenograft rejection in the pig-to-rat model. , 1997, Transplantation.

[4]  P. Halloran,et al.  Molecular mechanisms of new immunosuppressants. , 1996, Clinical transplantation.

[5]  A. Thomson,et al.  Mode of Action of Tacrolimus (FK506): Molecular and Cellular Mechanisms , 1995, Therapeutic drug monitoring.

[6]  O. Korsgren,et al.  Efficacy of immunosuppressive drugs in islet xenotransplantation: A study in the pig‐to‐rat model , 1995 .

[7]  J. Chapman,et al.  Immunosuppressive and diabetogenic effect of FK 506 on pancreatic islet xenotransplantation. , 1995, Transplantation proceedings.

[8]  W. Hofmann,et al.  Distinct intragraft cytokine gene expression patterns during acute hepatic rejection under cyclosporine versus FK 506 primary immunosuppression. , 1994, Transplantation proceedings.

[9]  M. Satake,et al.  Kinetics and character of xenoantibody formation in diabetic patients transplanted with fetal porcine islet cell clusters , 1994 .

[10]  M. Monden,et al.  Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected. , 1994, Transplantation proceedings.

[11]  T. Ocain,et al.  Rapamycin: A novel immunosuppressive macrolide , 1994, Medicinal research reviews.

[12]  Y. Nakajima,et al.  Successful combination therapy with FK 506 and 15-deoxyspergualin in pancreatic islet xenografting. , 1992, Transplantation proceedings.

[13]  Y. Nakajima,et al.  Immunosuppressive effect in combination therapy of cyclosporine A, FK 506, and 15-deoxyspergualin on pancreatic islet xenotransplantation. , 1992, Transplantation proceedings.

[14]  P. Kimball,et al.  Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporine. , 1991, Transplantation.

[15]  F. Dumont,et al.  The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. , 1989, Journal of immunology.

[16]  N. Yoshimura,et al.  EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITRO: I. Inhibition of Expression of Alloanticen‐Activated Suppressor Cells, As Well As Induction of Alloreactivity , 1989, Transplantation.

[17]  O. Korsgren,et al.  LARGE‐SCALE PRODUCTION OF FETAL PORCINE PANCREATIC ISLETLIKE CELL CLUSTERS: An Experimental Tool for Studies of Islet Cell Differentiation and Xenotransplantation , 1988, Transplantation.

[18]  S. Papson,et al.  “Model” , 1981 .

[19]  Ames,et al.  Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .

[20]  R. Morris.  Rapamycins: Antifungal, antitumor, antiproliferative, and immunosuppressive macrolides , 1992 .